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Analytical results are widely used to assess batch-by-batch conformity, pharmaceutical equivalence, 
as well as in the development of drug products. Despite this, few papers describing the measurement 
uncertainty estimation associated with these results were found in the literature. Here, we described a 
simple procedure used for estimating measurement uncertainty associated with the dissolution test of 
acetaminophen tablets. A fractionate factorial design was used to define a mathematical model that explains 
the amount of acetaminophen dissolved (%) as a function of time of dissolution (from 20 to 40 minutes), 
volume of dissolution media (from 800 to 1000 mL), pH of dissolution media (from 2.0 to 6.8), and rotation 
speed (from 40 to 60 rpm). Using Monte Carlo simulations, we estimated measurement uncertainty for 
dissolution test of acetaminophen tablets (95.2 ± 1.0%), with a 95% confidence level. Rotation speed 
was the most important source of uncertainty, contributing about 96.2% of overall uncertainty. Finally, 
it is important to note that the uncertainty calculated in this paper reflects the expected uncertainty to 
the dissolution test, and does not consider variations in the content of acetaminophen.
Keywords: Acetaminophen tablets/dissolution test/measurement uncertainty. Monte Carlo simulation.
INTRODUCTION
Analytical results (ARs) are the fundamental basis 
for the development of industry and science in modern 
society. In scientific research, ARs are used to compare 
experimental and control groups, test hypotheses, express 
relationships between variables, among other uses, in such 
a way that constitute the foundation for the discussion 
and conclusion of a particular study. In pharmaceutical 
industry, ARs are used to estimate income, assign a certain 
quality to materials, products or systems and compare 
them against certain internal or legal specifications or, 
among other applications. Usually, method validation, 
internal quality control protocols, arrangements of 
proficiency tests, and accreditation based on ISO/IEC 
17025 are adopted as a kind of quality assurance system 
that allows assessment of accuracy and assertiveness of 
ARs (Ellison, Williams, 2012).
Despite this, an AR will never be able to be an 
absolute and perfect representation of the parameter 
being measured. There will always be some uncertainty 
associated with the assertiveness of AR, even if all 
sources of uncertainty have been evaluated and corrected. 
This is because even the corrections applied have, by 
themselves, an associated uncertainty, not removing 
absolute uncertainty. Still, such a method of correction 
of uncertainty does not distinguish the variations from 
random effects, inherent to any experimental determination 
(Williams, 1998). Measurement uncertainty (MU) reflects 
a range of values that can be assigned to an AR using a 
specific methodology. It is not possible to correct the 
experimental results found for a true result and absolute 
through the MU (Ellison, Williams, 2012).
A measurement of uncertainty proposed in the Guide 
to the Expression of Uncertainty in Measurement (GUM) 
distinguishes both uncertainties from systematic and 
random effects (Ellison, Barwick, 1998a), by assessing 
the magnitude of the influence of some parameters on the 
measurement, and the determination of the impact of their 
uncertainties on AR. The first edition of the EURACHEM 
Guide entitled “Quantifying Uncertainty in Analytical 
Measurement” (Eurachem, 1995) was published in 1995. 
Focusing on various applications of analytical chemistry, 
from basic research up to routine analysis in major industries, 
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the guide was well received by the analytical community 
(Williams, 1998). Five years later, EURACHEM/CITAC 
published the second version of the guide, emphasizing new 
concepts such as the integration of measuring uncertainty 
and in-house quality assurance procedures.
Although these approaches are different from those 
usually used in analytical chemistry (Barwick, Ellison, 
1998, Ellison, Barwick, 1998b), the methodologies 
proposed in the GUM and EURACHEM/CITAC guides 
were applied in different areas such as, toxicological analysis 
(Eller et al., 2014), physical-chemical analysis (Leito et 
al., 2002), and quantitative analysis of pharmaceuticals 
by microbiological (Ghisleni et al., 2014a; Lourenço et 
al., 2007; Lourenço, 2013), spectrophotometric (Saviano, 
Lourenço, 2013) and chromatographic methods (Ghisleni 
et al., 2014b; Saviano et al., 2015; Okamoto, Traple, 
Lourenço, 2013). Traple et al. (2014) published a review 
of MU applied in pharmaceutical analysis (Traple et al., 
2014) describing the main sources of uncertainty such 
as sampling; instrumental effects; calibration mass and 
volumetric apparatus; purity of reagents and certified 
chemical substances; matrix effects and sample stability; 
analyst skills and training effects; environmental effects; 
random effects inherent to experimental determinations 
(Ellison, Williams, 2012).
In the third edition of the EURACHEM/CITAC 
guide, published in 2012 (Ellison, Williams, 2012), 
proficiency tests and application of Monte Carlo 
simulations were added as methods for the estimation of 
measurement uncertainty. The Monte Carlo simulation 
can be defined as randomly generating numbers by means 
of algorithms using probability distribution functions to 
obtain specific results on the process or object under study 
(Barat et al., 2006a; Barat et al., 2006), and it has been used 
in solving problems in several areas of science, including 
the chemical and pharmaceutical industry (Hammersley, 
Handscomb, 1964; Meimaroglou, Kiparissides, 2014). 
The main idea of the Monte Carlo simulation is that the 
extensive repetition of a random sampling process allows 
for obtaining a sufficiently large and random sample 
space for a statistical inference (Kroese et al., 2014). 
This random sampling is essential for simulating real 
mathematically modeled systems, and it also applies this 
statistical methodology to the concept of variability and 
measurement uncertainty, because it allows that the results 
generated in the output varies within a range determined 
by the algorithm as if they were random error fluctuations. 
The algorithms used in the Monte Carlo methods are 
simple, and have the ability to reduce the complexity of 
mathematically modeled systems (Kroese et al., 2014). 
This makes them applicable to, for example, processes of 
dissolution of controlled release pharmaceuticals (Barat 
et al., 2006b).
In the context of measurement uncertainty, the 
Monte Carlo simulation appeared first in 2008, as a 
document that describes the technique of propagation 
of distributions (JCGM, 2008). It is important to note 
that there are cases where the value of the measurement 
uncertainty will be relatively the same regardless of the 
methodology used. There are reports in the literature on the 
use of Monte Carlo simulation to ensure that the estimated 
probability functions for the factors of variability were 
indeed assertive, as a proof of concept of the classical 
methodology (Francisco, Saviano, Lourenço, 2014; 
Ghisleni et al., 2014b; Saviano, Madruga, Lourenço, 
2015; Diaconu et al., 2015). The differences between 
the methodologies are evident in scenarios with a lack of 
normality, lack of linearity or even when a mathematical 
expression relating the results and factors of variability is 
too complex to be calculated, taking the simplifications, 
which lead to deviations in measurement of uncertainty. 
In these cases, the Monte Carlo simulation seems to be 
the most appropriate methodology to be used (Ellison, 
Williams, 2012).
The dissolution test is a procedure officially 
established in the pharmacopoeias of various countries, 
which expresses the amount of dissolved substance 
as a function of time, using a dissolution media with 
specified pH, temperature and volume (ANVISA, 2010a; 
United States Pharmacopeia, 2012). Pharmacopeia 
monographs specify the device (basket, paddles or 
other) and appropriate conditions of dissolution test for 
each compound. The interests of the pharmaceutical 
community in the dissolution test began in the 1950s after 
observing that the disintegration profile of pharmaceutical 
dosage form did not explain the bioavailability profiles. 
Edwards was the first to report that if gastrointestinal 
absorption of a drug is fast, then the dissolution of 
pharmaceutical dosage form controls the bioavailability 
of the drug (Dokoumetzidis, Macheras, 2006), a preview 
of what would be proposed later by Amidon as the 
biopharmaceutical classification system (BCS) (Amidon 
et al., 1995). From the 1960s to the 1980s, the effects of 
dissolution on the bioavailability of drugs and the impact 
of formulations on bioavailability were widely studied 
(Dokoumetzidis, Macheras, 2006). Classic examples such 
as the ineffectiveness of tolbutamide and carbamazepine 
(Campagna et al., 1963; Meyer et al., 1992), and 
changes in the bioavailability of phenytoin and digoxin 
(Dokoumetzidis, Macheras, 2006). After investigation, 
these cases showed a correlation between changes in 
dissolution profiles and clinical toxicity or ineffectiveness.
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We found a few papers in the literature that described 
measurement uncertainty estimation associated with 
the dissolution test; however none of them assessed the 
contributions of dissolution test conditions of immediate 
release tablet dosage forms in the overall uncertainty. 
Here, we described a simple procedure used for estimating 
measurement uncertainty associated with the dissolution 
test of acetaminophen tablets based on Monte Carlo 
simulations.
MATERIAL AND METHODS
Immediate-release tablets and reference standard
Acetaminophen immediate-release tablets of 
1000 mg were purchased from Brazilian suppliers. An 
acetaminophen reference standard was provided by the 
United States Pharmacopeia.
Instrumentation
Dissolution tests were performed using a VanKel 
system (VanKel VK 7010) comprising a bath with 
six vessels and meeting the physical and mechanical 
specifications required by the USP chapter <711> 
(United States Pharmacopeia, 2012). The instrument was 
mechanically calibrated using paddles. An analytical 
balance (Shimadzu, AUY220), a pHmeter (Gehaka, 
PG1800), a UV-visible spectrophotometer (Thermo Fisher 
Scientific, Evolution 201, Waltham, MA, USA) were also 
used. Dissolution media, sample and reference standard 
solutions were prepared using calibrated volumetric flasks 
and pipettes.
Dissolution test
Dissolution tests were performed as described in 
Brazilian Pharmacopeia (ANVISA, 2010b) with some 
modifications to study how dissolution conditions 
affect the amount of acetaminophen dissolved. A 24-1IV 
fractionate factorial design with a central point was 
adopted to evaluate how time of dissolution (A, from 20 
to 40 minutes), volume of dissolution media (B, from 
800 to 1000 mL), pH of dissolution media (C, from 2.0 
to 6.8), and rotation speed (D, from 40 to 60 rpm), affects 
the amount of acetaminophen dissolved. All dissolution 
tests were performed in 3 vessels (replicas) using paddle 
apparatuses. The amounts of acetaminophen dissolved 
were determined by employing UV absorption at the 
wavelength of maximum absorbance at about 243 nm on 
filtered portions of the diluted sample solution compared 
with a reference standard solution, using dissolution 
medium as blank, as described in Brazilian pharmacopeia 
(ANVISA, 2010b). The mean amounts of acetaminophen 
dissolved and their relative standard deviations (RSD) 
were calculated.
Monte Carlo simulations
A mathematical regression model was adjusted 
to explain the amount of acetaminophen dissolved 
as a function of time of dissolution (A), volume of 
dissolution media (B), pH of dissolution media (C), and 
rotation speed (D). A combination of linear, quadratic, 
and interaction terms were selected to provide higher 
predictive power. A Box-Cox transformation was used 
to improve homoscedasticity and normal distribution of 
residual values.
Monte Carlo simulations were performed with 
20,000 random values of time of dissolution (5,000 
random values, normal distribution, mean = 30 minutes 
and standard deviation = 1 minute), volume of dissolution 
media (5,000 random values, normal distribution, mean = 
900 mL and standard deviation = 5 mL), pH of dissolution 
media (5,000 random values, normal distribution, mean 
= 5.80 and standard deviation = 0.05), and rotation speed 
(5,000 random values, normal distribution, mean = 50 rpm 
and standard deviation = 2 rpm).
RESULTS AND DISCUSSION
According to BCS, highly soluble and highly 
permeable drugs formulated into rapidly dissolving 
products do not need to be subjected to a profile comparison. 
Usually, a one-point test is required to confirm a release of 
85% or more of the active pharmaceutical ingredient (API) 
within 15 min. The impact of formulation composition 
in the dissolution is well established. However, slight 
changes in dissolution test conditions may impact the 
amount of API dissolved. Thus, this work focused on 
studying the effect of dissolution test conditions (such as 
time of dissolution, volume of dissolution media, pH of 
dissolution media, and rotation speed) in the amount of 
API dissolved and their contribution to overall uncertainty.
A fractionate factorial design was performed to 
statistically assess the magnitude of the influence of time 
of dissolution (A), volume f dissolution media (B), pH 
of dissolution media (C), and rotation speed (D) on the 
amount of acetaminophen dissolved. It was found that 
the data did not show a normal distribution; therefore a 
Box-Cox transformation was employed to statistically 
analyze the influence of inputs (A, B, C, and D) and 
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their interactions (AB, AC, AD, BC, BD, and CD) on 
the output. The statistical results are shown in a Pareto 
chart (Figure 1). The inputs above the critical value 
(1.71) showed statistically significant influence on the 
dissolution. Thus, the rotation speed (D) was determined 
as the most significant factor, followed by the time of 
dissolution (A), and later by an interaction between pH 
and rotation speed (CD). The relative standard deviations 
(RSD) for all dissolution conditions were less than 3%.
The mathematical model obtained from the analysis 
of factorial experiment should be evaluated regarding its 
predictive power and its adjustment to the experimental 
results. The predictive coefficient of determination 
(R2pred) is calculated to assess the predictive power of 
the mathematical model. The R2pred is calculated from the 
predicted residual error sum of squares (PRESS) statistic, 
and it provides a number that is directly proportional to the 
capacity of the mathematical model to predict the output 
with certainty. It is very important that the mathematical 
model has high predictive ability, since it will be used to 
calculate the Monte Carlo simulation outputs from the 
random inputs. 
The adjustment of a mathematical model usually is 
evaluated based on two parameters: R2 and R2adj. R2 is 
proportional to total variability explained by the model, 
and it will be close to 100% when the model is most 
adjusted to the experimental data. However, R2 may not 
be the most reliable variable as it may increase due to an 
increased number of non-significant factors included in the 
model. Thus, R2adj is often used to compare mathematical 
models, since it precisely adjusts to the number of factors 
included in the model.
The Pareto chart of the complete model includes 
the linear terms of time of dissolution (A), volume f 
dissolution media (B), pH of dissolution media (C), 
rotation speed (D), and their interactions (AB, AC, AD, 
BC, BD, and CD) are shown in Figure 1. Despite a high R2 
value (83.45%), the complete model was not well adjusted 
due to the inclusion of insignificant factors. A second 
model including the linear terms of time of dissolution 
(A), volume f dissolution media (B), pH of dissolution 
media (C), rotation speed (D), and the interaction between 
pH and rotation speed (CD) was adjusted. According to 
the Pareto chart (Figure 2) and ANOVA results (Table I), 
the most significant factors were rotation speed (D), time 
FIGURE 1 - Pareto chart for effects of time of dissolution (A), 
volume f dissolution media (B), pH of dissolution media (C), 
rotation speed (D), and their interactions (AB, AC, AD, BC, BD, 
and CD) on the amount of acetaminophen dissolved.
TABLE I - Analysis of variance (ANOVA) results of the amount of acetaminophen dissolved (%) as a function of time of dissolution 
(A), volume of dissolution media (B), pH of dissolution media (C), and rotation speed (D)
Source d.f. SS MS F p-value
Model 5 0.026204 0.026204 26.55 0.000**
     Linear 4 0.024847 0.024847 31.47 0.000**
          A 1 0.002836 0.002836 14.37 0.001**
          B 1 0.000311 0.000311 1.58 0.219
          C 1 0.000432 0.000432 2.19 0.150
          D 1 0.021268 0.021268 107.75 0.000**
     Interactions 1 0.001180 0.001180 5.98 0.021*
          CD 1 0.001180 0.001180 5.98 0.021*
Error 30 0.005921 0.000197
Total 35 0.032125
Legend: d.f.: degrees of freedom, SS: Sum of Squares, MS: Mean of Squares, F: calculated F statistics, and p-value: *significant 
(p-value<0.05) and **very significant (p-value<0.01).
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of dissolution (A), and the interaction between pH and 
rotation speed (CD), respectively. Regression equation 
and coefficients of determination (R2, R2adj, and R2pred) of 
this model is shown in Table II. A Box-Cox transformation 
(λ = 17, and geometric mean g = 0.941974) was used 
to normalize the amount of acetaminophen dissolved 
(output). The main effect and interaction effect plots are 
shown in Figure 3.
Response surface plot was obtained based on the 
mathematical model adjusted in order to show the effect 
of time of dissolution (A) and rotation speed (D) (Figure 
4) in the amount of acetaminophen dissolved (%), using 
volume (B) and pH (C) of dissolution media fixed at 
900 mL and 5.8, respectively. According to Figure 4, the 
amount of acetaminophen dissolved was more susceptible 
to time of dissolution (from 20 to 40 minutes) when a low 
rotation speed (40 rpm) is used. Moreover, at high rotation 
FIGURE 2 - Pareto chart for effects of time of dissolution (A), 
volume f dissolution media (B), pH of dissolution media (C), 
rotation speed (D), and the interaction of pH and rotation speed 
(CD) on the amount of acetaminophen dissolved.
FIGURE 3 - Main effects and interactions plots for the effect of time of dissolution (A, from 20 to 40 minutes), volume f dissolution 
media (B, from 800 to 1000 mL), pH of dissolution media (C, from 2.o to 6.8), rotation speed (D, from 40 to 60 rpm), and their 
interactions (AB, AC, AD, BC, BD, and CD) on the amount of acetaminophen dissolved.
TABLE II - Regression equation and coefficients of determination (R2, R2adj, and R2pred) of the amount of acetaminophen dissolved 
(%) as a function of time of dissolution (A), volume of dissolution media (B), pH of dissolution media (C), and rotation speed (D)
Regression equation R2 R2adj R2pred
(%λ-1)/(λ×g(λ-1)) = – 0.2132 + 0.001087×A + 0.000029×B 
– 0.01284×C + 0.001146×D + 0.000292×C×D 81.57% 78.50% 73.22%
λ = 17 (from Box-Cox transformation) and g = 0.9420 (geometric mean).
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speed (60 rpm), the amount of acetaminophen dissolved 
was almost not affected by time of dissolution (from 20 
to 40 minutes). Similarly, Figure 5 shows the response 
surface plot of the amount of acetaminophen dissolved 
(%) as a function of time of dissolution (A) and pH of 
dissolution media (C), with volume of dissolution media 
(B) and rotation speed (D) fixed at 900 mL and 50 rpm, 
respectively. At low rotation speed (40 rpm), the amount 
of dissolved acetaminophen slightly decreased as the pH 
increased. On the other hand, the amount of dissolved 
acetaminophen slightly increased as the pH increase, at 
high rotation speed (60 rpm.).
It did not escape our notice that pH, the input factor 
with the widest range (C, from 2.0 to 6.8) did not affect 
the amount of acetaminophen dissolved. pH alters the 
ionization of organic molecules, which alters the solubility 
of active pharmaceutical ingredient (API) in dissolution 
media. The non-significant effect of pH in the amount of 
acetaminophen dissolved may be explained due to its pKa 
(9.46), as well as the logS and logP curves as functions of 
pH. In other words, solubility of acetaminophen will be 
affected only in alkaline pH. Thus, solubility modifications 
in the pH range adopted in our study were not expected.
On the other hand, rotation speed significantly 
affects the amount of acetaminophen dissolved. This 
may be explained due to the effects of the hydrodynamic 
environment on the tablet dissolution rate (Kamba et 
al., 2003; Wu, Kildsig, Gahly, 2004). Rotation speed 
was even more significant than time of dissolution. We 
believe this may be explained because acetaminophen 
is a high solubility drug (BCS Class I) (Kalantzi et al., 
2006). Thus, the amount of acetaminophen dissolved in the 
range of time adopted in our study was close to the plateau 
level. Considering the importance of the hydrodynamic 
properties on the dissolution, the absence of volume as 
a factor of influence on the amount of acetaminophen 
dissolved could be questioned. However, the volume of 
dissolution media (900 mL) was large enough for the 
variation proposed in our study (from 800 to 1000 mL) to 
be not significant, since acetaminophen is a high solubility 
drug (Granber, Rasmuson, 1999). Because of the high 
solubility of acetaminophen, even under drastic changes 
in the significant factors in the dissolution test, minimal 
dissolution reached around 90%, which is considerably 
above the minimum of 80% in 30 min (ANVISA, 2010b; 
United States Pharmacopeia, 2012). Therefore, the 
dissolution test for acetaminophen tablets resists variations 
in experimental conditions.
The Monte Carlo simulation applied in estimating 
measurement uncertainty requires that the output response 
has a mathematical relationship with the inputs or sources of 
uncertainty. In addition, the inputs must have a probability 
density function, which can be `obtained from existing 
information about the process or evaluated experimentally. 
Random values of the density of probability of each input 
will be sampled and configured as mathematical expressions 
that will generate a simulated output result. This process is 
repeated a high number of times, generating a distribution of 
simulated results that will be used to determine uncertainty 
(Meyer, 2007; Ellison, Williams, 2012). 
Monte Carlo simulations were performed with 
5,000 random values of time of dissolution (5,000 random 
values, normal distribution, mean = 30 minutes and 
standard deviation = 1 minute), volume of dissolution 
media (5,000 random values, normal distribution, mean = 
900 mL and standard deviation = 5 mL), pH of dissolution 
media (5,000 random values, normal distribution, mean 
= 5.80 and standard deviation = 0.05), and rotation speed 
(5,000 random values, normal distribution, mean = 50 rpm 
FIGURE 4 - Response surface plot of the effect of time of 
dissolution (A) and rotation speed (D) on the amount of 
acetaminophen dissolved (%).
FIGURE 5 - Response surface plot of the effect of pH of 
dissolution media (C) and rotation speed (D) on the amount of 
acetaminophen dissolved (%).
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and standard deviation = 2 rpm). The pH of dissolution 
media used in the central point of fractionate factorial 
design was 4.4. Despite this, we performed Monte Carlo 
simulations using a dissolution media pH of 5.8, which is 
the pH used in the monograph of Brazilian pharmacopeia 
(ANVISA, 2010b).
The estimation of measurement uncertainty 
associated with the dissolution test would be much 
more difficult using the Eurachem/Citac Guidelines 
or spreadsheet methods. This is because the effects of 
dissolution conditions (such as time of dissolution, volume 
of dissolution media, pH of dissolution media, and rotation 
speed) on the amount of acetaminophen dissolved are not 
mathematically established. Measurement uncertainty 
estimation would be easier using other approaches such 
as method validation and repeatability/reproducibility 
studies. However, these approaches do not provide 
information of individual contributions of each source 
of uncertainty (Diaconu et al., 2015; Francisco, Saviano, 
Lourenço, 2016; Takano et al., 2017). Thus, we estimated 
the measurement uncertainty by Monte Carlo simulations 
performed using the regression equation of the amount 
of acetaminophen dissolved (%) as a function of time of 
dissolution (A), volume of dissolution media (B), pH of 
dissolution media (C), and rotation speed (D) (Table II).
This approach is in accordance with the principle of 
determination of measurement uncertainty described in 
the EURACHEM Guide (Ellison, Williams, 2012). From 
the simulated results of dissolution (output), we obtained 
a histogram plot (Figure 6) with normal distribution, 
characterized by its mean (95.2%) and standard deviation 
(0.5%). Expanded uncertainty may be obtained by the 
multiplication of standard deviation (0.5%) by a coverage 
factor (k = 2), which correspond to a 95% confidence 
interval (from 94.2 to 96.2%).
The ANOVA (Table I) and Pareto’s Chart (Figure 2) 
indicate that time of dissolution (A), rotation speed (D), 
and the interaction between pH of dissolution media and 
rotation speed (CD) were significant terms of regression 
equation (Table II). However, considering the individual 
contribution of each source of uncertainty, the rotation 
speed was the most important source of uncertainty, 
contributing about 96.2% of overall uncertainty (Figure 
7). The other factors contribute with virtually insignificant 
uncertainties. It is important to note that the uncertainty 
calculated in this paper reflects the expected uncertainty 
to the dissolution test, and does not consider variations 
in the content of acetaminophen. Pendrill raises some 
critical points on how to differentiate the uncertainty 
of measurement inherent in the manufacturing process. 
This question must be observed in the implementation of 
measurement uncertainty using EURACHEM and GUM 
methods (Pendrill, 2014).
CONCLUSION
The main factors of variability for the dissolution of 
acetaminophen were rotation speed, time of dissolution, 
and the interaction between pH and rotation speed. Using 
Monte Carlo simulations, we estimated measurement 
uncertainty for a dissolution test of acetaminophen tablets 
(95.2 ± 1.0%), with a 95% confidence level. Amounts of 
acetaminophen dissolved using the experimental range 
proposed in our study were found to be considerably 
above the minimum of 80% in 30 min. Finally, it is 
important to note that the uncertainty calculated in this 
paper reflects the expected uncertainty to the dissolution 
test and does not consider variations in the content of 
acetaminophen.
FIGURE 6 - Histogram plot obtained from 5,000 Monte Carlo 
simulations of the amount of acetaminophen dissolved.
FIGURE 7 - Pareto chart of the contribution of time of dissolution 
(A), volume of dissolution media (B), pH of dissolution media 
(C), and rotation speed (D) to overall uncertainty.
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